Literature DB >> 18664628

Development of regulatory T cells requires IL-7Ralpha stimulation by IL-7 or TSLP.

Renata Mazzucchelli1, Julie A Hixon, Rosanne Spolski, Xin Chen, Wen Qing Li, Veronica L Hall, Jami Willette-Brown, Arthur A Hurwitz, Warren J Leonard, Scott K Durum.   

Abstract

Interleukin-7 (IL-7), a cytokine produced by stromal cells, is required for thymic development and peripheral homeostasis of most major subsets of T cells. We examined whether regulatory T (Treg) cells also required the IL-7 pathway by analyzing IL-7Ralpha(-/-) mice. We observed a striking reduction in cells with the Treg surface phenotype (CD4, CD25, GITR (glucocorticoid-induced tumor necrosis factor [TNF]-like receptor), CD45RB, CD62L, CD103) or intracellular markers (cytotoxic T-lymphocyte-associated antigen-4, CTLA-4, and forkhead box transcription factor 3, Foxp3). Foxp3 transcripts were virtually absent in IL-7Ralpha(-/-) lymphoid tissues, and no Treg cell suppressive activity could be detected. There are 2 known ligands for IL-7Ralpha: IL-7 itself and thymic stromal lymphopoietin (TSLP). Surprisingly, mice deficient in IL-7 or the other chain of the TSLP receptor (TSLPR) developed relatively normal numbers of Treg cells. Combined deletion of IL-7 and TSLP receptor greatly reduced Treg cell development in the thymus but was not required for survival of mature peripheral Treg cells. We conclude that Treg cells, like other T cells, require signals from the IL-7 receptor, but unlike other T cells, do not require IL-7 itself because of at least partially overlapping actions of IL-7 and TSLP for development of Treg cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18664628      PMCID: PMC2569178          DOI: 10.1182/blood-2008-02-137414

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  93 in total

Review 1.  Regulatory T cells: key controllers of immunologic self-tolerance.

Authors:  S Sakaguchi
Journal:  Cell       Date:  2000-05-26       Impact factor: 41.582

2.  Coreceptor reversal in the thymus: signaled CD4+8+ thymocytes initially terminate CD8 transcription even when differentiating into CD8+ T cells.

Authors:  E Brugnera; A Bhandoola; R Cibotti; Q Yu; T I Guinter; Y Yamashita; S O Sharrow; A Singer
Journal:  Immunity       Date:  2000-07       Impact factor: 31.745

3.  CD38+ CD45RB(low) CD4+ T cells: a population of T cells with immune regulatory activities in vitro.

Authors:  S Read; S Mauze; C Asseman; A Bean; R Coffman; F Powrie
Journal:  Eur J Immunol       Date:  1998-11       Impact factor: 5.532

Review 4.  Expression vectors and delivery systems.

Authors:  G P Nolan; A R Shatzman
Journal:  Curr Opin Biotechnol       Date:  1998-10       Impact factor: 9.740

5.  Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.

Authors:  T Takahashi; Y Kuniyasu; M Toda; N Sakaguchi; M Itoh; M Iwata; J Shimizu; S Sakaguchi
Journal:  Int Immunol       Date:  1998-12       Impact factor: 4.823

6.  IL-2Rbeta links IL-2R signaling with Foxp3 expression.

Authors:  David M Soper; Deborah J Kasprowicz; Steven F Ziegler
Journal:  Eur J Immunol       Date:  2007-07       Impact factor: 5.532

7.  Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation.

Authors:  S Read; V Malmström; F Powrie
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

8.  Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

Authors:  T Takahashi; T Tagami; S Yamazaki; T Uede; J Shimizu; N Sakaguchi; T W Mak; S Sakaguchi
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

9.  CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.

Authors:  A M Thornton; E M Shevach
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

10.  Interleukin 7 receptor control of T cell receptor gamma gene rearrangement: role of receptor-associated chains and locus accessibility.

Authors:  S K Durum; S Candèias; H Nakajima; W J Leonard; A M Baird; L J Berg; K Muegge
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

View more
  60 in total

Review 1.  Resolving the identity myth: key markers of functional CD4+FoxP3+ regulatory T cells.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  Int Immunopharmacol       Date:  2011-05-31       Impact factor: 4.932

Review 2.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

3.  IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis.

Authors:  C C Walline; S Kanakasabai; J J Bright
Journal:  Genes Immun       Date:  2010-09-23       Impact factor: 2.676

Review 4.  Functions of thymic stromal lymphopoietin in immunity and disease.

Authors:  Yanlu Zhang; Baohua Zhou
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

Review 5.  TSLP and immune homeostasis.

Authors:  Shino Hanabuchi; Norihiko Watanabe; Yong-Jun Liu
Journal:  Allergol Int       Date:  2012-01-25       Impact factor: 5.836

6.  An in vivo IL-7 requirement for peripheral Foxp3+ regulatory T cell homeostasis.

Authors:  Grace Y Kim; Davinna L Ligons; Changwan Hong; Megan A Luckey; Hilary R Keller; Xuguang Tai; Philip J Lucas; Ronald E Gress; Jung-Hyun Park
Journal:  J Immunol       Date:  2012-05-16       Impact factor: 5.422

7.  Thymic stromal lymphopoietin is a key mediator of breast cancer progression.

Authors:  Purevdorj B Olkhanud; Yrina Rochman; Monica Bodogai; Enkhzol Malchinkhuu; Katarzyna Wejksza; Mai Xu; Ronald E Gress; Charles Hesdorffer; Warren J Leonard; Arya Biragyn
Journal:  J Immunol       Date:  2011-04-13       Impact factor: 5.422

8.  Differential response of regulatory and conventional CD4⁺ lymphocytes to CD3 engagement: clues to a possible mechanism of anti-CD3 action?

Authors:  Li Li; Junko Nishio; André van Maurik; Diane Mathis; Christophe Benoist
Journal:  J Immunol       Date:  2013-08-28       Impact factor: 5.422

Review 9.  Tissue-based class control: the other side of tolerance.

Authors:  Polly Matzinger; Tirumalai Kamala
Journal:  Nat Rev Immunol       Date:  2011-03       Impact factor: 53.106

Review 10.  TSLP in epithelial cell and dendritic cell cross talk.

Authors:  Yong-Jun Liu
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.